Original Articles
Vol. 6 No. 1 (2014): Reviews, Articles, Case Reports and Letters

EARLY AND LATE COMPLICATIONS RELATED TO CENTRAL VENOUS CATHETERS IN HAEMATOLOGICAL MALIGNANCIES: A RETROSPECTIVE ANALYSIS OF 1102 PATIENTS

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: February 18, 2014
4413
Views
786
Downloads
1522
HTML
Hematology

Authors

Several severe complications may be associated with the use of central venous catheters (CVC). We retrospectively evaluated on a large cohort of patients the incidence of CVC-related early and late complications. From 7/99 to 12/2005, 1102 CVC have been implanted at our Institution in 881 patients with haematological malignancies (142,202 total day number of implanted CVC). Early mechanic complications were 79 (7.2% - 0.55/1,000 days/CVC). Thirty-nine episodes of early infective complications (<1 week from CVC implant) occurred (3.5% - 0.3/1000 days/CVC): furthermore, 187 episodes of CVC-related sepsis (17% - 1.3/1000 days/CVC) were recorded. There were 29 episodes (2.6%) of symptomatic CVC-related thrombotic complications, with a median interval from CVC implant of 60 days (range 7 – 395). The rate of CVC withdrawal due to CVC-related complications was 26%. The incidence of CVC-related complications in our series is in the range reported in the literature, notwithstanding cytopenia often coexisting in haematological patients.

Downloads

Download data is not yet available.

Citations

Ethics Approval

Original Article
Salvatore Giacomo Morano, Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)
Lorenzo Coppola, Hematology “AOU” Sassari, Italy
Roberto Latagliata, Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)
Paola Berneschi, Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)
Antonio Chistolini, Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)
Alessandra Micozzi, Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)
Corrado Girmenia, Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)
Massimo Breccia, Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)
Gregorio Brunetti, Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)
Angela Matturro, Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)
Giovanni Rosa, Dipartimento Anestesia e Rianimazione, Azienda Policlinico Umberto I, "Sapienza" Università di Roma
Pietro Guerrisi, Dipartimento Scienze Radiologiche, Azienda Policlinico Umberto I, "Sapienza" Università di Roma
Franco Mandelli, Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)
Roberto Foà, Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)
Giuliana Alimena, Department of Cellular Biotechnology and Hematology ‘La Sapienza’ University Via Benevento 6, IT–00161 Rome (Italy)

How to Cite



“EARLY AND LATE COMPLICATIONS RELATED TO CENTRAL VENOUS CATHETERS IN HAEMATOLOGICAL MALIGNANCIES: A RETROSPECTIVE ANALYSIS OF 1102 PATIENTS” (2014) Mediterranean Journal of Hematology and Infectious Diseases, 6(1), p. e2014011. doi:10.4084/mjhid.2014.011.